A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19.

Autor: Oliveira EH; Molecular Immunogenetics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Monteleone-Cassiano AC; Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Tavares L; Department of Cellular and Molecular Biology and Pathogenic Bioagents, Center for Virus Research, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Santos JC; Molecular Immunogenetics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Lima TM; Department of Cellular and Molecular Biology and Pathogenic Bioagents, Center for Virus Research, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Gomes GF; Center for Research in Inflammatory Diseases, Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Tanaka PP; Molecular Immunogenetics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Monteiro CJ; Molecular Immunogenetics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Munuera M; Molecular Immunogenetics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Batah SS; Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Fabro AT; Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Faça VM; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Masson AP; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Donadi EA; Division of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Dametto M; Renato Archer Technology Information Center, Ministry of Science, Technology and Innovation, Campinas, SP, Brazil., Bonacin R; Renato Archer Technology Information Center, Ministry of Science, Technology and Innovation, Campinas, SP, Brazil., Martins RB Jr; Department of Cellular and Molecular Biology and Pathogenic Bioagents, Center for Virus Research, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Neto EA; Department of Cellular and Molecular Biology and Pathogenic Bioagents, Center for Virus Research, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., daSilva LLP; Department of Cellular and Molecular Biology and Pathogenic Bioagents, Center for Virus Research, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Cunha TM; Center for Research in Inflammatory Diseases, Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Passos GA; Molecular Immunogenetics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil; Laboratory of Genetics and Molecular Biology, Department of Basic and Oral Biology, Ribeirão Preto School of Dentistry, University of São Paulo (USP), Ribeirão Preto, SP, Brazil. Electronic address: passos@usp.br.

Publikováno v: Antiviral research [Antiviral Res] 2024 Sep; Vol. 229, pp. 105968. Date of Electronic Publication: 2024 Jul 14.

Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors.

Autor: Lanfredi GP; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Thomé CH; Regional Blood Center of Ribeirão Preto and Center for Cell Based Therapy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil., Ferreira GA; Regional Blood Center of Ribeirão Preto and Center for Cell Based Therapy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil., Silvestrini VC; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Masson AP; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Vargas AP; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Grassi ML; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Poersch A; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Candido Dos Reis FJ; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil., Faça VM; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Regional Blood Center of Ribeirão Preto and Center for Cell Based Therapy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. Electronic address: vitor.faca@fmrp.usp.br.

Publikováno v: Biochimica et biophysica acta. Proteins and proteomics [Biochim Biophys Acta Proteins Proteom] 2021 Jun; Vol. 1869 (6), pp. 140623. Date of Electronic Publication: 2021 Feb 17.

Schistosoma mansoni Heterochromatin Protein 1 (HP1) nuclear interactome in cercariae.

Autor: da Trindade NS; Biotechnology Institute and Multidisciplinary Group of Research, Science and Technology (RMPCT), Federal University of Uberlandia, Patos de Minas Campus, Patos de Minas, Minas Gerais, Brazil; Department of Animal Biology, Institute of Biology, University of Campinas, Campinas, Sao Paulo, Brazil., de Sousa Cardoso TC; Biotechnology Institute and Multidisciplinary Group of Research, Science and Technology (RMPCT), Federal University of Uberlandia, Patos de Minas Campus, Patos de Minas, Minas Gerais, Brazil., Costa GG; Department of Animal Biology, Institute of Biology, University of Campinas, Campinas, Sao Paulo, Brazil., Cruvinel GF; Department of Animal Biology, Institute of Biology, University of Campinas, Campinas, Sao Paulo, Brazil., Masson AP; Department of Biochemistry and Immunology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil., Lanfredi GP; Department of Biochemistry and Immunology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil., Allegretti SM; Department of Animal Biology, Institute of Biology, University of Campinas, Campinas, Sao Paulo, Brazil., Faça V; Department of Biochemistry and Immunology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil., de Souza Gomes M; Biotechnology Institute and Multidisciplinary Group of Research, Science and Technology (RMPCT), Federal University of Uberlandia, Patos de Minas Campus, Patos de Minas, Minas Gerais, Brazil., Morais ER; Biotechnology Institute and Multidisciplinary Group of Research, Science and Technology (RMPCT), Federal University of Uberlandia, Patos de Minas Campus, Patos de Minas, Minas Gerais, Brazil., Cabral FJ; Department of Animal Biology, Institute of Biology, University of Campinas, Campinas, Sao Paulo, Brazil. Electronic address: fjanku@unicamp.br.

Publikováno v: Journal of proteomics [J Proteomics] 2021 May 15; Vol. 239, pp. 104170. Date of Electronic Publication: 2021 Mar 01.

Fusion of Glioblastoma Tumor Antigens to Herpes Simplex Virus-1 Glycoprotein D Enhances Secondary Adaptive Immune Responses in a DNA Vaccine Strategy

Autor: De Molfetta Jb, Silva Id, Silva Cl, De Souza Prm, Peripato R, Rodrigues Rf, ão It, Wendy Martin Rios, Ferreira Lcds, Masson Ap, Arnoldi F, Diniz Mdo

Publikováno v: Journal of Vaccines & Vaccination.

Glioblastoma multiforme (GBM) is a recurrent and fatal cancer. EGFRvIII, MAGE-3 and GLEA-2 are antigens that are found in this highly heterogeneous tumor and that are absent in normal tissue. Usually, conventional GMB treatments do not prevent recurr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8dacfbe4f71bcacb126c8f858cc74deb
https://doi.org/10.4172/2157-7560.1000302

Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB 4 reduction but not PGE 2 increment.

Autor: Sorgi CA; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Soares EM; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Rosada RS; Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Bitencourt CS; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Zoccal KF; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Pereira PAT; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Fontanari C; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Brandão I; Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Masson AP; Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Ramos SG; Departamento de Patologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Silva CL; Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Frantz FG; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: frantz@usp.br., Faccioli LH; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: faccioli@fcfrp.usp.br.

Publikováno v: Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2020 Mar 01; Vol. 1866 (3), pp. 165574. Date of Electronic Publication: 2019 Oct 28.